Dashboard
Manage Tickers

TSVT 2seventy bio, Inc.

Nasdaq 2seventybio.com


$ 0.01 (0.2 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 603.30 $ -7.52 (-1.23 %)
DIA $ 465.63 $ -3.62 (-0.77 %)
SPY $ 666.42 $ -5.51 (-0.82 %)
TLT $ 92.11 $ 0.12 (0.13 %)
GLD $ 375.24 $ 2.37 (0.64 %)
$ 5
-- x --
-- x --
-- - --
$ 2.29 - $ 5.30
1,158,184
na
266.15M
$ 1.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2025 03-31-2025 10-Q
2 03-25-2025 12-31-2024 10-K
3 11-12-2024 09-30-2024 10-Q
4 08-08-2024 06-30-2024 10-Q
5 05-09-2024 03-31-2024 10-Q
6 03-07-2024 12-31-2023 10-K
7 11-14-2023 09-30-2023 10-Q
8 08-14-2023 06-30-2023 10-Q
9 05-10-2023 03-31-2023 10-Q
10 03-16-2023 12-31-2022 10-K
11 11-07-2022 09-30-2022 10-Q
12 08-10-2022 06-30-2022 10-Q
13 05-12-2022 03-31-2022 10-Q
14 03-22-2022 12-31-2021 10-K
15 12-01-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

2seventy-bio-acquisition-by-bristol-myers-squibb-on-track-to-close-in-q2-2025-hsr-waiting-period-expired-on-may-2-2025-tender-offer-expected-to-expire-on-may-13-2025
2seventy bio: Acquisition By Bristol Myers...
05/07/2025 20:16:57

Merger Agreement Details and Path to CompletionFollowing the successful closing of the tender offer, BMS will acquire all remai...

2seventy-bio-q1-eps-001-beats-012-estimate-sales-2294m-beat-1396m-estimate
2seventy bio Q1 EPS $0.01 Beats $(0.12) Es...
05/07/2025 20:14:09

2seventy bio (NASDAQ:TSVT) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.12) ...

Core News & Articles
2seventy Bio Announces Bristol Myers Squib...
05/07/2025 20:08:38

2seventy-bio-q4-2024-gaap-eps-037-misses-024-estimate-sales-2926-miss-12293m-estimate
2seventy bio Q4 2024 GAAP EPS $(0.37) Miss...
03/25/2025 20:11:49

2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.24...

morgan-stanley-maintains-equal-weight-on-2seventy-bio-lowers-price-target-to-5
Morgan Stanley Maintains Equal-Weight on 2...
03/14/2025 12:19:17

Morgan Stanley analyst Matthew Harrison maintains 2seventy bio (NASDAQ:TSVT) with a Equal-Weight and lowers the price target...

crude-oil-gains-1-ciena-earnings-top-views
Crude Oil Gains 1%; Ciena Earnings Top Views
03/11/2025 16:02:53

bristol-myers-squibb-scoops-up-its-blood-cancer-drug-partner-2seventy-bio-in-286-million-deal
Bristol Myers Squibb Scoops Up Its Blood C...
03/11/2025 14:17:35

Bristol Myers Squibb to acquire 2seventy Bio for $5.00 per share in a $286 million all-cash deal, an 88% premium to its last cl...

us-stocks-mixed-kohls-shares-plunge-after-q4-results
US Stocks Mixed; Kohl's Shares Plunge Afte...
03/11/2025 13:56:15

this-lennar-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday
This Lennar Analyst Is No Longer Bullish; ...
03/11/2025 13:14:54

top-3-health-care-stocks-that-may-keep-you-up-at-night-in-q1
Top 3 Health Care Stocks That May Keep You...
03/11/2025 12:55:38

leerink-partners-downgrades-2seventy-bio-to-market-perform-lowers-price-target-to-5
Leerink Partners Downgrades 2seventy bio t...
03/11/2025 12:20:30

Leerink Partners analyst Daina Graybosch downgrades 2seventy bio (NASDAQ:TSVT) from Outperform to Market Perform and lowers ...

why-paymentus-holdings-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket
Why Paymentus Holdings Shares Are Trading ...
03/11/2025 10:55:36

us-stocks-likely-to-open-higher-after-mondays-selloff-tsla-stock-rebounds-from-its-worst-fall-in-5-years-after-trump-backs-musk-analyst-says-pullbacks-are-normal
US Stocks Likely To Open Higher After Mond...
03/11/2025 10:52:59

U.S. stock futures rose on Tuesday following Monday's heavy selloff. Futures of all four benchmark indices surged in premar...

Core News & Articles
Reported Earlier, 2seventy bio Agrees To B...
03/11/2025 05:41:10

Transaction Details and Path to CompletionUnder the terms of the agreement, BMS will promptly commence a tender offer to acquir...

novo-nordisk-eyes-2025-regulatory-filing-for-hemophilia-candidate-after-encouraging-pediatric-study-data
Novo Nordisk Eyes 2025 Regulatory Filing F...
02/07/2025 12:50:07

Novo Nordisk's phase 3 trial of Mim8 in children with hemophilia A showed a 0.53 mean annualized bleeding rate, with 74.3% ...

2seventy-bio-reports-preliminary-full-year-us-abecma-sales-says-company-registers-242m-in-us-abecma-sales-in-2024-with-approximately-184m-of-cash-and-equivalents-as-of-december-31
2Seventy Bio Reports Preliminary Full-year...
02/06/2025 12:13:48

2seventy-bio-q3-2024-gaap-eps-019-beats-022-estimate-sales-13534m-miss-15036m-estimate
2seventy bio Q3 2024 GAAP EPS $(0.19) Beat...
11/12/2024 12:02:00

2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) ...

earnings-scheduled-for-november-12-2024
Earnings Scheduled For November 12, 2024
11/12/2024 08:32:46

2seventy-bio-earnings-preview
2seventy bio Earnings Preview
11/11/2024 14:02:23

europe-drug-regulators-advising-panel-recommends-approval-of-novo-nordisks-australia-approved-hemophilia-drug
Europe Drug Regulator's Advising Panel Rec...
10/18/2024 17:21:46

Novo Nordisk's Alhemo (concizumab) receives a positive opinion from the EMA's CHMP for hemophilia A or B with inhibitor...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION